source
- STAT+: ARCH-launched Neumora stops depression programA new AI model to improve trial enrollment, importing drugs from Canada, and more biotech news from The ReadoutSTAT · 1mo ago↗ source
- Edgewise heart drug passes key trial testStill, the results leave somewhat unclear how different the company’s drug is than marketed hypertrophic cardiomyopathy medicines from Bristol Myers Squibb and Cytokinetics.BioPharma Dive · 1mo ago↗ source
- STAT+: Pharmalittle: We’re reading about Medicare and obesity drugs, Germany’s pricing plans, and moreWeight loss drugs will be available through Medicare starting next month, thanks to a program that is supposed to be temporary but may be difficult to endSTAT · 1mo ago↗ source